IBA Pioneers Theranostic Advancements, Empowering the Market to Produce Astatine-211
Imaging Technology
DECEMBER 12, 2023
Furthermore, an IBA cyclotron Cyclone 70XP , installed in France in 2008, has enabled multiple research programs already. Despite its scarcity, At-211, an alpha emitter, is used in clinical research for targeted alpha-therapies in the field of oncology to treat brain, thyroid, ovarian, breast, prostate cancer.
Let's personalize your content